We screened 21 extended spectrum b-lactamase-producing Enterobacteriaceae with reduced susceptibility to carbapenems for carbapenemase production. Five strains (four Klebsiella pneumoniae and one Citrobacter freundii) showed carbapenemase production, which was identified as OXA-48. The bla OXA-48 gene was detected on~54 kb plasmids belonging to IncA/C in one case. Two isolates harboured IS1999, which is involved in bla OXA-48 mobilization. Carbapenem resistance in enterobacteria should be regarded as an emerging clinical problem in our hospital and necessitates rigorous surveillance in order to limit its spread.
INTRODUCTION
Currently, emergence and dissemination of carbapenemase-producing Enterobacteriaceae is of great concern worldwide, mainly in Mediterranean countries (Poirel et al., 2004) . Carbapenemases belonging to Ambler classes A, B and D have been reported among Enterobactericeae.
Our study aimed to screen enterobacteria for carbapenemase production.
METHODS

From January 2009 to February 2011, we isolated 21 isolates of
Enterobacteriaceae from different wards in a Tunisian hospital with reduced susceptibility to carbapenems, including imipenem (zone of inhibition diameter ¡22 mm) and/or ertapenem (zone diameter ¡18 mm). Microbial identification was performed using the API 20 E system (bioMérieux) and antibiotic susceptibility testing was performed by using the disc diffusion method according to the criteria of the Clinical and Laboratory Standards Institute (CLSI, 2011) . Extended Spectrum b-lactamase (ESBL) detection was performed by the double disc synergy test. Antibiotic MICs were determined by the E-test method (bioMérieux) and interpreted according to CLSI guidelines (CLSI, 2011) . Diffusible carbapenemase detection was performed by using the modified Hodge test (MHT) (Lee et al., 2001) . Class B metallo-b-lactamase detection was performed using the disc test with EDTA as the inhibitor. All MHT-positive isolates were selected for this study. Transferability of the bla OXA-48 gene was studied by conjugation and/or electroporation experiments using Escherichia coli recipient strain J53-2Rif r and E. coli reference strain DH10B (Invitrogen SARL) respectively. bla OXA-48 and bla KPC genes were detected by PCR (Poirel et al., 2004) . The characterization of bla SHV , bla TEM , bla CTX-M , bla CIT , bla DHA and bla OXA-48 b-lactamase genes was performed by PCR and sequencing (Poirel et al., 2004) . The presence of insertion sequence IS1999 was detected by PCR (Poirel et al., 2004) . Incompatibility groups (Inc) of E. coli transconjugants (n53) or electroporant (n51) were determined by a PCR-based replicon typing method (Carattoli et al., 2005) . The genetic relationship between the different isolates was studied by pulsed-field gel electrophoresis (PFGE) with the restriction enzyme XbaI (Gaul et al., 2007) .
RESULTS AND DISCUSSION
Only five isolates (four K. pneumoniae and one C. freundii) were positive for MHT but negative for metallo-b-lactamase detection. These five isolates and their transconjugants or electroporants harboured the bla OXA-48 gene. These isolates were recovered from patients hospitalized in four different wards (Table 1) . XbaI-PFGE analysis of the four OXA-48-producing K. pneumoniae isolates revealed four distinct macrorestriction patterns indicating no genetic relationship. Ertapenem MICs for all five isolates revealed increased levels of resistance (0.75-32 mg l 21 ), contrary to MIC values of meropenem and imipenem, which were in the susceptible range for all strains (Table 2) . Ertapenem is known to be the antimicrobial most affected by OXA-48 carbapenemase. Low MIC levels of the two other carbapenems can result in lack of OXA-48 detection, thus enhancing the silent spread of this resistance mechanism (Poirel et al., 2004) . In our study, the 16 remaining isolates with reduced susceptibility to ertapenem (13 K. pneumoniae and 3 Enterobacter cloacae) were recovered from urology (n56), medicine (n55), surgery (n52), paediatrics (n51) and intensive care unit (n52) departments. Carbapenem resistance in these pathogens could be due to combination of ESBL production and reduced porin production or porin loss (Poirel et al., 2004) . Multiple resistance mechanisms were usually present in the OXA-48-positive strains, including various b-lactamases, as well as various genes coding for resistance to other antibiotics (Poirel et al., 2004) .
The five OXA-48-producing isolates harboured ESBL genes bla CTX-M-15 (n53) and bla CTX-M-14 (n51) as well as other b-lactamase genes (bla SHV-1 , bla TEM-1 and bla CMY-4 ). Additionally, all isolates were resistant to aminoglycosides, fluoroquinolones and trimethoprim-sulfamethoxazole but remained susceptible to colistin (Table 2) .
Transconjugants or electroporants were obtained for all K. pneumoniae isolates but could not be obtained for the C. freundii isolate, suggesting a possible chromosomal location of the bla OXA-48 gene in this particular isolate. The plasmids of transconjugants and transformants carrying the bla OXA-48 gene did not harbour any other ESBL genes. However, in the K. pneumoniae transconjugant I4600 that was additionally resistant to cefotaxime, trimethoprimsulfamethoxazole and tetracycline, we detected bla CMY-4 and bla OXA-48 by PCR (Table 2 ).
According to the literature, bla OXA-48 is carried on~50-70 kb plasmids belonging to P, IncL/M or IncA/C incompatibility groups (Carrër et al., 2010; Glupczynski et al., 2012; Ktari et al., 2011; Poirel et al., 2012) . In our study, the bla OXA-48 gene was located on plasmids of~54 kb in the five Enterobacteriaceae. The only isolate identified with incompatibility group IncA/C was K. pneumoniae transconjugant I4600 (Table 2) . In this isolate, bla OXA-48 and bla CMY-4 genes were detected, indicating that these genes are located on the same plasmid. The insertion sequence IS1999, which is involved in mobilization and expression of b-lactamase resistance genes, has been described in the genetic environment of bla OXA-48 (Poirel et al., 2004) . However, IS1999 was found upstream of bla OXA-48 in only two K. pneumoniae isolates ( Table 2 ).
The risk factors for carbapenem resistance acquisition that were encountered by our patients were previous hospitalization, previous carbapenem treatment and co-morbidities (Table 1) . Introduction of such isolates from other countries has been illustrated in recent reports, such as the importation and subsequent cross-transmission of OXA-48-producing K. pneumoniae in France from Tunisia and Morocco Levast et al., 2011) . Recent travel to other Mediterranean countries could not be determined for any of our patients. Different carbapenems, in combination with amikacin (two cases), ofloxacin (one case) and colimycin (one case), were used for treatment and outcome was fatal in one patient (Table 1) . The clinical significance of the presence of a carbapenemase gene in an isolate with carbapenem MICs in the susceptible range is currently unknown (Cohen Stuart et al., 2010) . For the one case of death observed in our study, we believe that several severe underlying diseases of this patient were the cause of the fatal outcome.
Here, we report the emergence of five OXA-48 carbapenemase-producing Enterobacteriaceae in a Tunisian hospital. This underlines the necessity of enhanced surveillance and 
